Immusoft Receives $4M In Funding From The California Institute For Regenerative Medicine (CIRM) Read More
Immusoft Announces FDA Clearance Of IND Application For ISP-001 For MPS I, The First Engineered B Cell Therapy To Enter Into Clinical Trials Read More
selectION, Inc. Advances Lead Program for Treatment of T Cell Mediated Autoimmune Diseases to Clinical Development Read More